Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000945234-04-000154
Filing Date
2004-03-12
Accepted
2004-03-12 16:22:38
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ANNAUL REPORT YEAR ENDED DECEMBER 31, 2003 o12239e10vk.txt 10-K 355244
3 PER SHARE EARNINGS COMPUTATION STATEMENT o12239exv11.txt EX-11 2602
4 CONSENT OF DELOITTE & TOUCHE LLP o12239exv23.txt EX-23 518
5 SECTION 302 CERTIFICATION - CEO o12239exv31w1.txt EX-31.1 3660
6 SECTION 302 CERTIFICATION - CFO o12239exv31w2.txt EX-31.2 3722
7 SECTION 906 CERTIFICATION - CEO o12239exv32w1.txt EX-32.1 1428
8 SECTION 906 CERTIFICATION - CFO o12239exv32w2.txt EX-32.2 1551
  Complete submission text file 0000945234-04-000154.txt   371268
Mailing Address 887 GREAT NORTHERN WAY VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY - VANCOUVER A1 V5T 4T5 6047077000
QLT INC/BC (Filer) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17082 | Film No.: 04666395
SIC: 2834 Pharmaceutical Preparations